These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15720811)

  • 1. Characteristics of stem cells from human neuroblastoma cell lines and in tumors.
    Walton JD; Kattan DR; Thomas SK; Spengler BA; Guo HF; Biedler JL; Cheung NK; Ross RA
    Neoplasia; 2004; 6(6):838-45. PubMed ID: 15720811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors.
    Ross RA; Biedler JL; Spengler BA
    Cancer Lett; 2003 Jul; 197(1-2):35-9. PubMed ID: 12880957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neuroblastoma I-type cells are malignant neural crest stem cells.
    Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
    Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.
    Acosta S; Lavarino C; Paris R; Garcia I; de Torres C; Rodríguez E; Beleta H; Mora J
    BMC Dev Biol; 2009 Feb; 9():12. PubMed ID: 19216736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
    Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
    Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.
    Ross RA; Walton JD; Han D; Guo HF; Cheung NK
    Stem Cell Res; 2015 Sep; 15(2):419-26. PubMed ID: 26342562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.
    Samaraweera L; Grandinetti KB; Huang R; Spengler BA; Ross RA
    BMC Cancer; 2014 May; 14():309. PubMed ID: 24885481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.
    Cui H; Ma J; Ding J; Li T; Alam G; Ding HF
    J Biol Chem; 2006 Nov; 281(45):34696-704. PubMed ID: 16982619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
    Li J; Kretzner L
    Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nestin is a potential mediator of malignancy in human neuroblastoma cells.
    Thomas SK; Messam CA; Spengler BA; Biedler JL; Ross RA
    J Biol Chem; 2004 Jul; 279(27):27994-9. PubMed ID: 15117961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
    Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
    Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification.
    Hossain MM; Banik NL; Ray SK
    Gene; 2013 Oct; 529(1):27-36. PubMed ID: 23941992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells.
    Ross RA; Hein AM; Braca JA; Spengler BA; Biedler JL; Scammell JG
    Oncol Res; 2002; 13(2):87-94. PubMed ID: 12392156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.
    Ciccarone V; Spengler BA; Meyers MB; Biedler JL; Ross RA
    Cancer Res; 1989 Jan; 49(1):219-25. PubMed ID: 2535691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives.
    Biagiotti T; D'Amico M; Marzi I; Di Gennaro P; Arcangeli A; Wanke E; Olivotto M
    Stem Cells; 2006 Feb; 24(2):443-53. PubMed ID: 16100002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
    Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.